nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Author Index
|
|
|
2014 |
38 |
S1 |
p. S67-S69 3 p. |
artikel |
2 |
Case Report Evaluation Board
|
|
|
2014 |
38 |
S1 |
p. vi- 1 p. |
artikel |
3 |
Congress Organization Committee
|
|
|
2014 |
38 |
S1 |
p. vi- 1 p. |
artikel |
4 |
Editorial Board
|
|
|
2014 |
38 |
S1 |
p. i- 1 p. |
artikel |
5 |
PP-033 ABDOMINAL S. AUREUS ABSCESS CONSIDERED AS LYMPHOMA RECURRENCE IN A LYMPHOMA PATIENT
|
Cetinkaya, G. |
|
2014 |
38 |
S1 |
p. S38- 1 p. |
artikel |
6 |
PP-042 A CASE OF HEPATOCELLULAR CARCINOMA ACCOMPANIED BY CASTLEMAN'S DISEASE
|
Aslaner, M. |
|
2014 |
38 |
S1 |
p. S41- 1 p. |
artikel |
7 |
PP-080 A CASE OF NEUTROPENIA DUE TO ACUTE EXPOSURE WITH ALUMINUM PHOSPHIDE
|
Dagli, M. |
|
2014 |
38 |
S1 |
p. S51- 1 p. |
artikel |
8 |
PP-076 A CASE OF RELAPSED HODGKIN’S LYMPHOMA IDENTIFIED AFTER 20 YEARS
|
Ozaydin, S. |
|
2014 |
38 |
S1 |
p. S50- 1 p. |
artikel |
9 |
PP-065 A CASE OF WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA REFRACTORY TOECULIZUMAB THERAPY
|
Cagliyan, G. Akgun |
|
2014 |
38 |
S1 |
p. S47-S48 2 p. |
artikel |
10 |
PP-025 ADVANCED PHASE CHRONIC MYELOID LEUKEMIA RESISTANT TO IMATINIB, NILOTINIB, DASATINIB AND INTERFERON WITHOUT ABL KINASE MUTATION
|
Malkan, Ü.Y. |
|
2014 |
38 |
S1 |
p. S35- 1 p. |
artikel |
11 |
PP-005 A HEREDITARY HEMORAGIC TELANGIECTASIA (OSLER-WEBER-RENDU DISEASE) PRESENTING WITH SEVERE ANEMIA
|
Ekmen, M.Ö. |
|
2014 |
38 |
S1 |
p. S29- 1 p. |
artikel |
12 |
PP-064 A METHOTREXATE RELATED CASE WITH LYMPHADENOPATHIES
|
Uysal, A. Oruc |
|
2014 |
38 |
S1 |
p. S47- 1 p. |
artikel |
13 |
PP-106 A MYELODYSPLASTIC SYNDROME WITH LEUKEMIC TRANSFORMATION DIAGNOSED WITH LUMBAR PUNCTION AFTER BREAST CANCER TREATMENT
|
Taktakoglu, O. |
|
2014 |
38 |
S1 |
p. S60- 1 p. |
artikel |
14 |
PP-020 AN ESSENTIAL THROMBOCYTOSIS CASE, WHICH TRANSFORMED TO ACUTE MYELOID LEUKEMIA AFTER 12 YEARS
|
Malkan, Ü.Y. |
|
2014 |
38 |
S1 |
p. S33-S34 2 p. |
artikel |
15 |
PP-111 AN IMAGE OF VISUAL FEAST OR SINISTER OPPONENT: BLASTING ALL THE EXPLOSIVES IN LUNGS
|
Taktakoglu, O. |
|
2014 |
38 |
S1 |
p. S62- 1 p. |
artikel |
16 |
PP-068 A NOVEL BIOMARKER FOR DRUG RESISTANCE IN CHRONIC MYELOID LEUKEMIA: MICRORNA-17
|
Baran, Y. |
|
2014 |
38 |
S1 |
p. S48- 1 p. |
artikel |
17 |
PP-088 A PATIENT WITH MYELOPROLIFERATIVE NEOPLASM EXHIBITING HETEROZYGOUS JAK2V617F MUTATION AND TRISOMY 14 ROBERTSONIAN TRANSLOCATION SIMULTANEOUSLY
|
Gokgoz, Z. |
|
2014 |
38 |
S1 |
p. S53-S54 2 p. |
artikel |
18 |
PP-047 APOPTOTIC EFFECTS OF NON-EDIBLE PARTS OF PUNICA GRANATUM ON HUMAN MULTIPLE MYELOMA CELLS
|
Kiraz, Y. |
|
2014 |
38 |
S1 |
p. S43- 1 p. |
artikel |
19 |
PP-044 A RARE CASE OF PLASMACYTOMA FOLLOWED CHRONIC LYMPHOCYTIC LEUKEMIA
|
Aslaner, M. |
|
2014 |
38 |
S1 |
p. S42- 1 p. |
artikel |
20 |
PP-032 A RARE CAUSE OF HEMATURIA IN AN IMMUNOSUPPRESSED PATIENT: BK VIRUS NEPHROPATHY
|
Karakilic, E. |
|
2014 |
38 |
S1 |
p. S38- 1 p. |
artikel |
21 |
PP-098 A RARE CAUSE OF HEMOLYTIC ANEMIA: CATASTROPHIC LEPTOSPIROSIS CASE WITH ALTERNATIVE TREATMENT
|
Taktakoglu, O. |
|
2014 |
38 |
S1 |
p. S57- 1 p. |
artikel |
22 |
PP-029 A RARE CAUSE OF MACROSCOPIC HEMATURIA IN CHILD: GRANULOCYTIC SARCOMA
|
Karaman, S. |
|
2014 |
38 |
S1 |
p. S37- 1 p. |
artikel |
23 |
PP-095 A RARE PRESENTATION OF HELLP SYNDROME AT 16TH WEEK OF GESTATION
|
Taktakoglu, O. |
|
2014 |
38 |
S1 |
p. S56- 1 p. |
artikel |
24 |
PP-021 ASHERMAN SYNDROME WITH FACTOR 7 DEFICIENCY: CASE REPORT
|
Malkan, Ü.Y. |
|
2014 |
38 |
S1 |
p. S34- 1 p. |
artikel |
25 |
PP-052 A SINGLE CENTER RESULTS OF FLOW CYTOMETRIC DETERMINATION OF MINIMAL RESIDUAL DISEASE IN PEDIATRIC B-ALL PATIENTS
|
Albayrak, D. |
|
2014 |
38 |
S1 |
p. S44- 1 p. |
artikel |
26 |
PP-115 ATYPICALLY LOCALIZED HODGKIN’S LYMPHOMA
|
Uysal, A. |
|
2014 |
38 |
S1 |
p. S63- 1 p. |
artikel |
27 |
PP-030 AUTOIMMUNE MANIFESTATIONS IN MYELODYSPLASTIC SYNDROMES
|
Hacioglu, S. |
|
2014 |
38 |
S1 |
p. S37- 1 p. |
artikel |
28 |
PP-027 AUTOLOGOUS PERIPHERAL STEM CELL TRANSPLANTATION IN SOLID TUMORS:SINGLE INSTITUTION EXPERIENCE
|
Soyer, N. |
|
2014 |
38 |
S1 |
p. S36- 1 p. |
artikel |
29 |
PP-108 BORTEZOMIB: A PROMISING TARGET FOR ENDOPLASMIC RETICULUM STRESS-INDUCED APOPTOSIS IN CHRONIC MYELOID LEUKEMIA
|
Gunel, N. Selvi |
|
2014 |
38 |
S1 |
p. S61- 1 p. |
artikel |
30 |
PP-041 CD5(–) MANTLE CELL LYMPHOMA: A CASE REPORT
|
Aslaner, M. |
|
2014 |
38 |
S1 |
p. S41- 1 p. |
artikel |
31 |
PP-109 CHROMATIN MODIFICATION GENES PLAY PIVOTAL ROLE IN BORTEZOMIB INDUCED GROWTH SUPPRESSION IN CHRONIC MYELOID LEUKEMIA
|
Caliskan, C. |
|
2014 |
38 |
S1 |
p. S61- 1 p. |
artikel |
32 |
PP-039 COEXISTENCE OF FACTOR X DEFICIENCY AND PROTHROMBOTIC MTHFR HOMOZYGOTE MUTATION IN PREGNANCY: CASE REPORT
|
Malkan, Ü.Y. |
|
2014 |
38 |
S1 |
p. S40- 1 p. |
artikel |
33 |
PP-104 COMPARISON OF PULSE WITH HIGH DOSE STEROID TREATMENT IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA
|
Dagli, M. |
|
2014 |
38 |
S1 |
p. S59-S60 2 p. |
artikel |
34 |
PP-107 CYTOMEGALOVIRUS REACTIVATION RATES AFTER HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION: SINGLE CENTER EXPERIENCE
|
Özgür, G. |
|
2014 |
38 |
S1 |
p. S60-S61 2 p. |
artikel |
35 |
PP-024 CYTOMORPHOLOGICAL AND BIOCHEMICAL MARKERS OF THE FUNCTIONAL SYSTEMS STATE IN THE PLASMA DONORS’ BODY
|
Ubaydullaeva, Z.I. |
|
2014 |
38 |
S1 |
p. S34-S35 2 p. |
artikel |
36 |
PP-060 CYTOTOXIC AND APOPTOTIC EFFECTS OF FISETIN, HESPERETIN AND VITEXINON ACUTE PROMYELOCYTIC LEUKAEMIA CELLS
|
Gokbulut, A. Adan |
|
2014 |
38 |
S1 |
p. S46- 1 p. |
artikel |
37 |
PP-092 CYTOTOXIC AND CYTOSTATIC EFFECTS OF PONATINIB ON IMATINIB-SENSITIVE AND -RESISTANT CHRONIC MYELOID LEUKEMIA CELLS
|
Yandim, M. Kartal |
|
2014 |
38 |
S1 |
p. S55- 1 p. |
artikel |
38 |
PP-118 DASATINIB REGULATES LNCRNA EXPRESSIONS IN CHRONIC MYELOID LEUKEMIA
|
Kayabas, C. |
|
2014 |
38 |
S1 |
p. S64- 1 p. |
artikel |
39 |
PP-082 DELAYED ENGRAFTMENT DUE TO CANDIDA NORVEGENSIS IN HDC AND SCT PATIENT
|
Ozaydin, S. |
|
2014 |
38 |
S1 |
p. S52- 1 p. |
artikel |
40 |
PP-001 DETERMINATION OF REFERENCE INTERVALS FOR HEMOGLOBIN OF ADANA POPULATION
|
Yildiz, S. Menziletoğlu |
|
2014 |
38 |
S1 |
p. S28- 1 p. |
artikel |
41 |
PP-094 DETERMINING EXPRESSION PROFILES OF MIRNAS THAT POTENTIALLY REGULATE STAT5A AND STAT5B IN DASATINIB TREATED K562 CELLS WITH EVALUATING APOPTOSIS
|
Yilmaz, A. |
|
2014 |
38 |
S1 |
p. S55- 1 p. |
artikel |
42 |
PP-045 DEVELOPMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA IN A PATIENT WITH JAK2V617F POSITIVE ESSENTIALTHROMBOCYTHEMIA
|
Ertop, Ş. |
|
2014 |
38 |
S1 |
p. S42- 1 p. |
artikel |
43 |
PP-009 DIAGNOSTIC VALUE OF DETERMINING THE LEVEL OF CYTOKINE (SIL-2R/CD25) IN CHILDREN WITH VARIOUS HEMATOLOGICAL DISEASES
|
Illarionova, O. |
|
2014 |
38 |
S1 |
p. S30- 1 p. |
artikel |
44 |
PP-050 DIFFUSE LARGE B-CELL LYMPHOMA IN β-THALASSEMIA MAJOR
|
Patir, P. |
|
2014 |
38 |
S1 |
p. S43-S44 2 p. |
artikel |
45 |
PP-087 DO WE REALLY TREAT ESSENTIAL THROMBOCYTHEMIA? A CLINICAL TRIAL OF 148 PATIENTS WITH ET
|
Cetin, G. |
|
2014 |
38 |
S1 |
p. S53- 1 p. |
artikel |
46 |
PP-099 DOWN-REGULATED SUV39H1 GENE EXPRESSION LEVEL BY RESVERATROL LEADS TO INHIBITION OF CELL DIVISION VIA ALTERING THE HISTONE METHYLATION OF HISTONE H3 IN CHRONIC MYELOID LEUKEMIA
|
Mutlu, Z. |
|
2014 |
38 |
S1 |
p. S58- 1 p. |
artikel |
47 |
PP-100 DRAMATIC RESPONSE OF A PATIENT WITH SEPTIC SHOCK: AN EXTRACORPOREAL CYTOKINE ADSORPTION EXPERIENCE
|
Sumbul, H. |
|
2014 |
38 |
S1 |
p. S58- 1 p. |
artikel |
48 |
PP-016 ECULIZUMAB PLUS CYCLOSPORIN TREATMENT FOR PAROXYSMAL NOCTURNAL HEMOGLOBINURIA FOLLOWED BY SUCCESSFUL ALLOGENEIC TRANSPLANTATION
|
Unal, A. |
|
2014 |
38 |
S1 |
p. S32- 1 p. |
artikel |
49 |
PP-054 EFFICACY OF IDELALISIB IN CLL SUBPOPULATIONS HARBORING DEL(17P) AND OTHER ADVERSE PROGNOSTIC FACTORS: RESULTS FROM A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
|
Sharman, J. |
|
2014 |
38 |
S1 |
p. S44-S45 2 p. |
artikel |
50 |
PP-022 EFFICIENCY OF PLERIXAFOR FOR AUTOLOGOUS STEM CELL MOBILIZATION: SINGLE-CENTER EXPERIENCE
|
Akyol, G. |
|
2014 |
38 |
S1 |
p. S34- 1 p. |
artikel |
51 |
PP-069 ELTROMBOPAG IN REFRACTORY APLASTIC ANEMIA
|
Cagliyan, G. Akgun |
|
2014 |
38 |
S1 |
p. S48-S49 2 p. |
artikel |
52 |
PP-078 ENGRAFTMENT KINETICS IN HDC AND STEM-CELL TRANSPLANTATION PATIENTS
|
Ozavdin, S. |
|
2014 |
38 |
S1 |
p. S51- 1 p. |
artikel |
53 |
PP-102 EPIGALLOCATECHIN-3-GALLATE TRIGGERS AUTOPHAGY MEDIATED CELL DEATH VIA UP-REGULATION OF TMEM74 GENE EXPRESSION IN CHRONIC MYELOID LEUKEMIA CELLS
|
Goker, B. |
|
2014 |
38 |
S1 |
p. S59- 1 p. |
artikel |
54 |
PP-117 EVALUATING EXPRESSION PATTERNS OF STAT5A AND STAT5B REGULATED MIRNASIN BORTEZOMIB TREATED CML CELL MODEL WITH INCREASED APOPTOSIS LEVELS
|
Kipcak, S. |
|
2014 |
38 |
S1 |
p. S64- 1 p. |
artikel |
55 |
PP-116 EVALUATION OF FEBRILE NEUTROPENIC EPISODES IN HEMATOPOIETIC STEM CELL TRANSPLANTATIONS
|
Ozkan, M. Comert |
|
2014 |
38 |
S1 |
p. S63-S64 2 p. |
artikel |
56 |
PP-055 EVALUATION THE RELATIONSHIP BETWEEN MTHFR GENE POLYMORPHISM AND PREGNANCY LOSS
|
Keren, F. |
|
2014 |
38 |
S1 |
p. S45- 1 p. |
artikel |
57 |
PP-067 EXPANSION OF BONE MARROW DERIVED MESENCHYMAL STEM CELLS USING A GMP COMPLIANT CLOSED SYSTEM BIOREACTOR AND QUALITY ANALYSIS OF THE EXPANDED CELLS
|
Kozanoglu, I. |
|
2014 |
38 |
S1 |
p. S48- 1 p. |
artikel |
58 |
PP-062 EXPRESSION LEVELS OF CERAMIDE-METABOLISING GENES IN NEWLY DIAGNOSED AND TYROSINE KINASE INHIBITOR-RESISTANT CHRONIC MYELOID LEUKEMIA (CML) PATIENTS: THE DISCOVERY OF NOVEL TARGETS IN CML
|
Yandim, M. Kartal |
|
2014 |
38 |
S1 |
p. S47- 1 p. |
artikel |
59 |
PP-011 FACTORS EFFECTING HOSPITALIZATION FREQUENCY OF SICKLE CELL ANEMIA PATIENTS
|
Ilhan, G. |
|
2014 |
38 |
S1 |
p. S31- 1 p. |
artikel |
60 |
PP-004 FASCIOLA HEPATICA ASSOCIATED WITH MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE
|
Karakuş, A. |
|
2014 |
38 |
S1 |
p. S29- 1 p. |
artikel |
61 |
PP-105 FOLLOW UP OF A PATIENT TREATED WITH BEVACIZUMAB: A DOUBLE EDGED SWORD
|
Taktakoglu, O. |
|
2014 |
38 |
S1 |
p. S60- 1 p. |
artikel |
62 |
PP-043 GIANT HEMOPHILIC PSEUDOTUMOR OF THE ILIOPSOAS: CASE REPORT
|
Malkan, Ü.Y. |
|
2014 |
38 |
S1 |
p. S41- 1 p. |
artikel |
63 |
PP-070 HEMOGLOBIN O ARAB IN AN ASYMPTOMATIC PATIENT
|
Duran, M. |
|
2014 |
38 |
S1 |
p. S49- 1 p. |
artikel |
64 |
PP-017 HEREDITARY HYPERFERRITINEMIA-CATARACT SYNDROME: CASE REPORT
|
Kutlu, O. |
|
2014 |
38 |
S1 |
p. S32-S33 2 p. |
artikel |
65 |
PP-010 HERMANSKY-PUDLAK SYNDROME: REPORT OF A CASE AND REVIEW OF THE LITERATURE
|
Ilhan, G. |
|
2014 |
38 |
S1 |
p. S30-S31 2 p. |
artikel |
66 |
PP-120 HIGH DOSE CHEMOTHERAPY IN PATIENTS WITH MANTLE CELL LYMPHOMA
|
Ozaydin, S. |
|
2014 |
38 |
S1 |
p. S65- 1 p. |
artikel |
67 |
PP-036 HODGKIN TRANSFORMATION IN CHRONIC LYMPHOCYTIC LEUKEMIA
|
Güneş, G. |
|
2014 |
38 |
S1 |
p. S39- 1 p. |
artikel |
68 |
PP-014 HYPERACUTE TUMOR LYSIS SYNDROME INDUCED BY RITUXIMAB IN MANTLE CELL LYMPHOMA
|
Patir, P. |
|
2014 |
38 |
S1 |
p. S32- 1 p. |
artikel |
69 |
PP-056 HYPEREOSINOPHILIC SYNDROME: CASE REPORT
|
Malkan, Ü.Y. |
|
2014 |
38 |
S1 |
p. S45- 1 p. |
artikel |
70 |
PP-057 IMATINIB-INDUCED ACUTE RHABDOMYOLYSIS IN NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA PATIENT
|
Malkan, Ü.Y. |
|
2014 |
38 |
S1 |
p. S45-S46 2 p. |
artikel |
71 |
PP-015 IMPACT ON PROGNOSIS OF K-RAS MUTATION AND C-MYC OVEREXPRESSION AT DIFFUSE LARGE B-CELL LYMPHOMAS
|
Ertas, S. Ketenci |
|
2014 |
38 |
S1 |
p. S32- 1 p. |
artikel |
72 |
PP-074 INHIBITION OF JUMONJI C DOMAIN CONTAINING HISTONE DEMETHYLASES IN ACUTE MYELOID LEUKEMIA
|
Hastar, N. |
|
2014 |
38 |
S1 |
p. S50- 1 p. |
artikel |
73 |
PP-091 INVESTIGATING THE POTENTIAL EFFECTS OF SUNITINIB IN K-562 CHRONIC MYELOGENOUS LEUKEMIA CELL LINE AND ASSESSMENT OF GENE PROFILING
|
Ozkan, M. Comert |
|
2014 |
38 |
S1 |
p. S54-S55 2 p. |
artikel |
74 |
PP-026 INVESTIGATING THE ROLE OF JAK/STAT PATHWAY UPON DASATINIB INDUCE DAPOPTOSIS FOR CML CELL MODEL K562
|
Dalgic, C. Tunakan |
|
2014 |
38 |
S1 |
p. S35-S36 2 p. |
artikel |
75 |
PP-073 INVESTIGATION OF MUTATIONS IN CHRONIC MYELOID LEUKEMIA AND ASSESSMENT OF THE RELATION BETWEEN MUTATIONS AND THE CLINICAL RESPONSE
|
Aytan, P. |
|
2014 |
38 |
S1 |
p. S50- 1 p. |
artikel |
76 |
PP-028 INVESTIGATION ON THE FREQUENCY OF CD10, CD30, BCL-2, BCL-6, MUM-1, P53, KI-67 AND IMPACT TO THE PROGNOSIS IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA
|
Haciboncuk, P. |
|
2014 |
38 |
S1 |
p. S36- 1 p. |
artikel |
77 |
PP-040 IS THE BURKITT LEUKEMIA PROGNOSIS AS GOOD AS EXPECTED?
|
Malkan, Ü.Y. |
|
2014 |
38 |
S1 |
p. S40- 1 p. |
artikel |
78 |
PP-121 IS THERE A CORRELATION BETWEEN SERUM GALACTOMANNAN POSITIVITY AND HRCT FINDINGS IN HEMATOPOIETIC STEM CELL RECIPIENTS?
|
Ozkan, M. Comert |
|
2014 |
38 |
S1 |
p. S65- 1 p. |
artikel |
79 |
PP-093 ITP WITH PSORIASIS
|
Ozlu, C. |
|
2014 |
38 |
S1 |
p. S55- 1 p. |
artikel |
80 |
PP-048 JAK/STAT SIGNALING PATHWAY GENES IN THE REGULATION OF TYROSINE KINASE INHIBITORS INDUCED AND CLINICAL PROCESS IN CHRONIC MYELOID LEUKEMIA PATIENTS
|
Kiraz, Y. |
|
2014 |
38 |
S1 |
p. S43- 1 p. |
artikel |
81 |
PP-002 LIFE-THREATENING MASSIVE THROMBOEMBOLISM AFTER LAPAROSCOPICSPLENECTOMY IN AN IDIOPATHIC THROMBOCYTOPENIC PATIENT
|
Uz, B. |
|
2014 |
38 |
S1 |
p. S28- 1 p. |
artikel |
82 |
PP-006 MANAGEMENT OF MANTLE CELL LYMPHOMA IN THE ELDERLY: A RETROSPECTIVE MULTICENTER STUDY
|
Keklik, M. |
|
2014 |
38 |
S1 |
p. S29- 1 p. |
artikel |
83 |
PP-031 MANAGEMENT OF TEETH EXTRACTIONS OF A PATIENT WITH FACTOR XI DEFICIENCY
|
Gokgoz, Z. |
|
2014 |
38 |
S1 |
p. S37-S38 2 p. |
artikel |
84 |
PP-089 METASTASIS OF BREAST CANCER IN BONE MARROW WITH LEUKOERYTHROBLASTIC REACTION: A CASE REPORT
|
Ergen, S. |
|
2014 |
38 |
S1 |
p. S54- 1 p. |
artikel |
85 |
PP-012 MIXED PHENOTYPE ACUTE LEUKEMIA ARISING IN THE SETTING OF MYELODYSPLASTIC SYNDROME: A CASE REPORT
|
Tuncer, H.H. |
|
2014 |
38 |
S1 |
p. S31- 1 p. |
artikel |
86 |
PP-071 MULTIPLE MYELOMA PRESENTING WITH CLIVUS PLASMACYTOMA
|
Duran, M. |
|
2014 |
38 |
S1 |
p. S49- 1 p. |
artikel |
87 |
PP-058 MYASTENIA GRAVIS AND WALDENSTROM MACROGLOBULINEMIA: IS COMMON IMMUNOLOGIC MECHANISM POSSIBLE?
|
Malkan, Ü.Y. |
|
2014 |
38 |
S1 |
p. S46- 1 p. |
artikel |
88 |
PP-072 NAILFOLD CAPILLAROSCOPY MAY BE A USEFUL TOOL FOR DETECTION OF MICROVASCULAR CHANGES IN PATIENTS WITH PSV
|
Yolbas, S. |
|
2014 |
38 |
S1 |
p. S49- 1 p. |
artikel |
89 |
PP-097 NEUTROPHIL LYMPHOCYTE RATIO AND MEAN PLATELET VOLUME AS AN INFLAMMATORY MARKER IN GOUT ARTHRITIS
|
Maden, M. |
|
2014 |
38 |
S1 |
p. S57- 1 p. |
artikel |
90 |
PP-051 NILOTINIB INDUCES APOPTOSIS THROUGH JAK/STAT PATHWAY MEMBERS STAT5A & STAT5B IN K562 CML CELL MODEL
|
Yavuz, T. Guliyeva |
|
2014 |
38 |
S1 |
p. S44- 1 p. |
artikel |
91 |
PP-019 OCULAR ADNEXAL LYMPHOMAS: SINGLE CENTER EXPERIENCE
|
Ozkan, M. Comert |
|
2014 |
38 |
S1 |
p. S33- 1 p. |
artikel |
92 |
PP-053 OSTEOSCLEROSIS IN SYSTEMIC MASTOCYTOSIS
|
Alp, G. |
|
2014 |
38 |
S1 |
p. S44- 1 p. |
artikel |
93 |
PP-112 PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA PRESENTING AS CEREBRAL VENOUS SINUS THROMBOSIS
|
Sumbul, H. |
|
2014 |
38 |
S1 |
p. S62-S63 2 p. |
artikel |
94 |
PP-007 PERITONEAL LYMPHOMATOSIS AFTER SPLENECTOMY IN TWO PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
|
Ayesh (Haj Yousef), M. |
|
2014 |
38 |
S1 |
p. S30- 1 p. |
artikel |
95 |
PP-103 PLASMAPHERESIS CROSSES THE BORDERS: BECOMING HIGHWAY IN ACUTE LIVER FAILURE INSTEAD OF BRIDGE TO LIVER TRANSPLANTATION
|
Taktakoglu, O. |
|
2014 |
38 |
S1 |
p. S59- 1 p. |
artikel |
96 |
PP-075 PREOPERATIVE THERAPEUTIC PLASMA EXCHANGE FOR SEVERE HYPERTHYROIDISM IN A PATIENT WITH PEPTIC ULCER PERFORATION
|
Turgut, S. |
|
2014 |
38 |
S1 |
p. S50- 1 p. |
artikel |
97 |
PP-037 PRIMARY BREAST LYMPHOMA
|
Gokgoz, Z. |
|
2014 |
38 |
S1 |
p. S39-S40 2 p. |
artikel |
98 |
PP-119 RADIOISOTOPE SYNOVECTOMY RESULTS IN EGE ADULT HEMOPHILIA CENTER (2001–2011): 11 YEARS EXPERIENCE
|
Patir, P. |
|
2014 |
38 |
S1 |
p. S64-S65 2 p. |
artikel |
99 |
PP-122 RED CELL DISTRIBUTION WIDTH HAS A PREDICTABLE VALUE FOR DIFFERENTIATION OF PROVOKED AND UNPROVOKED VENOUS THROMBOEMBOLISM
|
Ertop, Ş. |
|
2014 |
38 |
S1 |
p. S65- 1 p. |
artikel |
100 |
PP-035 REFRACTORY CHRONIC GRAFT VERSUS HOST DISEASE DEVELOPING IN POST-TRANSPLANT FIFTH YEAR
|
Güneş, G. |
|
2014 |
38 |
S1 |
p. S39- 1 p. |
artikel |
101 |
PP-114 RELAPSE/REFRACTORY MYELOMA AND CARFILZOMIB
|
Uysal, A. |
|
2014 |
38 |
S1 |
p. S63- 1 p. |
artikel |
102 |
PP-003 RETROSPECTIVE ANALYSIS OF ELTROMBOPAG FOR THE TREATMENT OF REFRACTORY PRIMARY IMMUNE THROMBOCYTOPENIA IN THE SOUTH OF TURKEY
|
Dal, M.S. |
|
2014 |
38 |
S1 |
p. S28-S29 2 p. |
artikel |
103 |
PP-110 RITUXIMAB: A PRINCE CHARMING OF “PLASMAPHERESIS RESISTANT THROMBOTIC MICROANGIOPATHY CASE”
|
Sumbul, H. |
|
2014 |
38 |
S1 |
p. S61-S62 2 p. |
artikel |
104 |
PP-034 SCREENING TEST SEROPREVALENCE OF BLOOD DONORS: THE RESULTS OF BALCALI HOSPITAL BLOOD CENTER, UNIVERSITY OF CUKUROVA
|
Karaboga, G. |
|
2014 |
38 |
S1 |
p. S38- 1 p. |
artikel |
105 |
PP-083 SECONDARY ALL IN MULTIPLE MYELOMA PATIENT WHO UNDERWENT HDC AND SCT
|
Ozaydin, S. |
|
2014 |
38 |
S1 |
p. S52- 1 p. |
artikel |
106 |
PP-081 SEVERE RENAL FAILURE DUE TO HIGH DOSE METHOTREXATE IN ACUTE LYMPHOBLASTIC LEUKEMIA ASSOCIATED WITH PREDISPOSING FACTORS: CASE REPORT
|
Dagli, M. |
|
2014 |
38 |
S1 |
p. S52- 1 p. |
artikel |
107 |
PP-013 SEVERE STAPHYLOCOCCAL SEPSIS PRESENTING WITH MICROAGIOPATHIC HEMOLYTIC ANEMIA AND THROMBOCYTOPENIA: A CASE REPORT
|
Connell, B. |
|
2014 |
38 |
S1 |
p. S31-S32 2 p. |
artikel |
108 |
PP-023 STUDY OF FREQUENCY OF NEUROLEUKEMIA OCCURRENCE AND EFFECTIVE THERAPY IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA
|
Babayev, M.E.S. |
|
2014 |
38 |
S1 |
p. S34- 1 p. |
artikel |
109 |
PP-059 TARGETING SPHINGOSINE KINASE-1/SPHINGOSINE-1-PHOSPHATE RECEPTOR 2SIGNALLING PATHWAY TO OVERCOME T315I MUTATION IN 32DCL3 CELLS
|
Gokbulut, A. Adan |
|
2014 |
38 |
S1 |
p. S46- 1 p. |
artikel |
110 |
PP-061 TET2, ASXL1, IDH1 AND IDH2 MUTATIONS IN NON-CML MYELOPROLIFERATIVE NEOPLASMS
|
Soyer, N. Akad |
|
2014 |
38 |
S1 |
p. S46-S47 2 p. |
artikel |
111 |
PP-101 THE CATARACT FORMATION DUE TO THE USE OF DEFERIPRONE IN A PATIENT WITH THALASSEMIA MAJOR
|
Karagün, B. Şahin |
|
2014 |
38 |
S1 |
p. S58-S59 2 p. |
artikel |
112 |
PP-049 THE CONTRIBUTION OF CD49F TO THE FLOW CYTOMETRIC MINIMAL RESIDUAL DISEASE DETERMINATION IN PEDIATRIC B CELL ACUTE LYMPHOBLASTIC LEUKEMIA
|
Albayrak, C. |
|
2014 |
38 |
S1 |
p. S43- 1 p. |
artikel |
113 |
PP-079 THE EFFECT OF ANEMIA AND RED CELL TRANSFUSIONS ON MORTALITY IN YOUNG AND ELDERLY INTENSIVE CARE PATIENTS WITH NOSOCOMIAL INFECTION
|
Kutlucan, L. |
|
2014 |
38 |
S1 |
p. S51- 1 p. |
artikel |
114 |
PP-008 THE FOUR YEARS TRANSPLANT ACTIVITY OF A SINGLE STEM CELL TRANSPLANT CENTER
|
Guner, S. Izmir |
|
2014 |
38 |
S1 |
p. S30- 1 p. |
artikel |
115 |
PP-113 THE IMPORTANCE OF LDH AS A BIOMARKER ON PAROXYSMAL NOCTURNAL HEMOGLOBINURIA CASES
|
Sumbul, H. |
|
2014 |
38 |
S1 |
p. S63- 1 p. |
artikel |
116 |
PP-046 THE INVESTIGATION OF VEGF-A, MMP-2, MMP-9, TIMP-1, TIMP-2 GENES EXPRESSION ALTERATIONS AND METHYLATION LEVELS IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA
|
Inandiklioglu, N. |
|
2014 |
38 |
S1 |
p. S42- 1 p. |
artikel |
117 |
PP-084 THE OUTCOME OF HDC AND ASCT IN PATIENTS WITH RECURRENT MEDULLOBLASTOMA
|
Ozaydin, S. |
|
2014 |
38 |
S1 |
p. S52- 1 p. |
artikel |
118 |
PP-066 THERAPEUTIC POTENTIAL OF FISETIN, VITEXIN AND HESPERETIN ON CHRONIC MYELOID LEUKEMIA CELLS
|
Gokbulut, A. Adan |
|
2014 |
38 |
S1 |
p. S48- 1 p. |
artikel |
119 |
PP-018 THE ROLE OF DNMT AND HDAC IN THE EXPERIMENTAL HEMORRHAGIC CYSTITIS MODEL IN RATS
|
Ozaydin, S. |
|
2014 |
38 |
S1 |
p. S33- 1 p. |
artikel |
120 |
PP-085 THE ROLE OF FLT3-ITD AND CEBPA MUTATIONS ON PROGNOSIS OF ACUTE LYMPHOBLASTIC LEUKEMIA IN TURKISH PATIENTS
|
Uluca, I. |
|
2014 |
38 |
S1 |
p. S53- 1 p. |
artikel |
121 |
PP-086 THROMBOCYTE COUNT, MPW AND PDW CHANGES IN PATIENTS WHO RECEIVED CHEMOTHERAPY
|
Toka, B. |
|
2014 |
38 |
S1 |
p. S53- 1 p. |
artikel |
122 |
PP-038 TREATMENT OF CHRONIC MYELOID LEUKEMIA IN PREGNANCY
|
Güneş, G. |
|
2014 |
38 |
S1 |
p. S40- 1 p. |
artikel |
123 |
PP-077 TREATMENT OF HIGH RISK EWING’S SARCOMA WITH HDC AND SCT
|
Ozaydın, S. |
|
2014 |
38 |
S1 |
p. S50-S51 2 p. |
artikel |
124 |
PP-063 TWO CASES WITH PRIMARY IMMUNE DEFICIENCY AND NEOPLASTIC LYMPHOID PROLIFERATION
|
Malkan, Ü.Y. |
|
2014 |
38 |
S1 |
p. S47- 1 p. |
artikel |
125 |
PP-090 UPPER AND LOWER EXTREMITY GANGRENES WITH HEPARIN INDUCED THROMBOCYTOPENIA IN A HEMODIALYSIS PATIENT
|
Erkoc, R. |
|
2014 |
38 |
S1 |
p. S54- 1 p. |
artikel |
126 |
PP-096 URINARY EARLY KIDNEY INJURY MOLECULES IN CHILDREN WITH BETA-THALASSEMIA MAJOR
|
Sen, V. |
|
2014 |
38 |
S1 |
p. S56-S57 2 p. |
artikel |
127 |
Scientific Board
|
|
|
2014 |
38 |
S1 |
p. vi- 1 p. |
artikel |
128 |
Scientific Program
|
|
|
2014 |
38 |
S1 |
p. vii- 1 p. |
artikel |
129 |
SP-054 ACUTE MYELOGENOUS LEUKEMIA
|
Gumuscu, Burak |
|
2014 |
38 |
S1 |
p. S22- 1 p. |
artikel |
130 |
SP-040 ADVANCES IN MOBILIZATION FAILURE OF HEMATOPOIETIC STEM CELLS (HSC)
|
Azar, Nabih |
|
2014 |
38 |
S1 |
p. S19- 1 p. |
artikel |
131 |
SP-033 ANTIFUNGAL TREATMENTS IN FEBRILE NEUTROPENIA: FROM SCIENTIFIC TRIALS TO CLINICAL PRACTICE
|
Pagano, Livio |
|
2014 |
38 |
S1 |
p. S17- 1 p. |
artikel |
132 |
SP-028 APPROACH IN RELAPSED AND REFRACTORY MULTIPLE MYELOMA
|
Delforge, Michel |
|
2014 |
38 |
S1 |
p. S14- 1 p. |
artikel |
133 |
SP-006 ATOMIC BOMBS, RADIATION THERAPY AND CML. SOMETHING'S ROTTEN IN DENMARK
|
Gale, Robert Peter |
|
2014 |
38 |
S1 |
p. S3- 1 p. |
artikel |
134 |
SP-024 CD19-SPECIFIC CHIMERIC ANTIGEN RECEPTOR-MODIFIED T CELLS FOR RELAPSED, REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA
|
Melenhorst, J. Joseph |
|
2014 |
38 |
S1 |
p. S12- 1 p. |
artikel |
135 |
SP-023 CHRONIC LYMPHOCYTIC LEUKEMIA: OLD AND NEW THERAPIES
|
Ghia, Paolo |
|
2014 |
38 |
S1 |
p. S11-S12 2 p. |
artikel |
136 |
SP-025 CML RESPONSE MONITORING IN 2014
|
Chaudhri, Naeem A. |
|
2014 |
38 |
S1 |
p. S12- 1 p. |
artikel |
137 |
SP-032 DIAGNOSIS AND MANAGEMENT OF PERI-OPERATIVE RISK (BLEEDING AND THROMBOSIS)
|
Uz, Burak |
|
2014 |
38 |
S1 |
p. S16-S17 2 p. |
artikel |
138 |
SP-020 DIAGNOSIS, CLINICAL MANAGEMENT AND STEWARDSHIP FOR INVASIVE FUNGAL DISEASE IN HAEMATO-ONCOLOGY
|
Agrawal, S.G. |
|
2014 |
38 |
S1 |
p. S10- 1 p. |
artikel |
139 |
SP-061 EPIGENETIC THERAPY FOR TREATMENT PEDIATRIC ACUTE MYELOID LEUKEMIA
|
Nemirovchenko, V.S. |
|
2014 |
38 |
S1 |
p. S25- 1 p. |
artikel |
140 |
SP-012 EXTRACORPOREAL PHOTOPHERESIS FOR SOLID ORGAN TRANSPLANTS REJECTION: A NEW THERAPEUTIC OPTION?
|
Del Fante, Claudia |
|
2014 |
38 |
S1 |
p. S5-S6 2 p. |
artikel |
141 |
SP-001 FRONTLINE THERAPY OF CHRONIC MYELOID LEUKEMIA (CML)
|
Kantarjian, Hagop |
|
2014 |
38 |
S1 |
p. S1- 1 p. |
artikel |
142 |
SP-014 GRAFT ENGINEERING TO PREVENT VIRAL INFECTION
|
Saglio, Francesco |
|
2014 |
38 |
S1 |
p. S6-S7 2 p. |
artikel |
143 |
SP-043 HAPLOIDENTICAL STEM CELL TRANSPLANTATION
|
Nagler, Arnon |
|
2014 |
38 |
S1 |
p. S19- 1 p. |
artikel |
144 |
SP-010 HODGKIN'S LYMPHOMA: DIAGNOSIS AND STAGING
|
Özdemir, Evren |
|
2014 |
38 |
S1 |
p. S4- 1 p. |
artikel |
145 |
SP-047 HOW I MANAGE DLBL
|
Halahleh, Khalid |
|
2014 |
38 |
S1 |
p. S21- 1 p. |
artikel |
146 |
SP-045 HOW I MANAGE INDOLENT NON-HOGDKIN LYMPHOMA?
|
Sahin, Berksoy |
|
2014 |
38 |
S1 |
p. S19-S20 2 p. |
artikel |
147 |
SP-026 HOW I TREAT ESSENTIAL THROMBOCYTHEMIA
|
Schwarz, Jiří |
|
2014 |
38 |
S1 |
p. S12-S14 3 p. |
artikel |
148 |
SP-027 HOW I TREAT PATIENTS WITH POLYCYTHEMIA VERA
|
Petrides, Petro E. |
|
2014 |
38 |
S1 |
p. S14- 1 p. |
artikel |
149 |
SP-011 HOW SHOULD WE TREAT HODGKIN LYMPHOMA? FIRST LINE THERAPY, EVALUATION OF RESPONSE AND SECOND LINE THERAPY
|
Levis, Alessandro |
|
2014 |
38 |
S1 |
p. S4-S5 2 p. |
artikel |
150 |
SP-003 IMPACT OF IRON OVERLOAD AND POTENTIAL BENEFIT FROM IRON CHELATION IN LOW-RISK MYELODYSPLASTIC SYNDROME AND BEFORE AND AFTER BMT
|
Rachmilewitz, Eliezer |
|
2014 |
38 |
S1 |
p. S2- 1 p. |
artikel |
151 |
SP-046 MANTLE CELL LYMPHOMA
|
De Souza, Carmino Antonio |
|
2014 |
38 |
S1 |
p. S20-S21 2 p. |
artikel |
152 |
SP-062 MECHANISMS OF HAEMATOPOIETIC STEM CELL MOBILIZATION IN HODGKIN'S LYMPHOMA PATIENTS
|
Petrova, G. |
|
2014 |
38 |
S1 |
p. S25- 1 p. |
artikel |
153 |
SP-065 MODERN PRINCIPLES OF MANAGEMENT OF THALASSEMIA INTERMEDIA
|
Alimirzoeva, Zohra |
|
2014 |
38 |
S1 |
p. S26-S27 2 p. |
artikel |
154 |
SP-031 MRD MONITORING IN MULTIPLE MYELOMA: WHERE ARE WE NOW?
|
Paiva, Bruno |
|
2014 |
38 |
S1 |
p. S16- 1 p. |
artikel |
155 |
SP-007 MYELODYSPLASTIC SYNDROMES: OLD AND NEW CLASSIFICATION AND PROGNOSTIC SYSTEMS
|
Greenberg, Peter |
|
2014 |
38 |
S1 |
p. S4- 1 p. |
artikel |
156 |
SP-021 NEW ANTIBIOTIC STRATEGY IN FEBRILE NEUTROPENIA
|
Uzun, Omrum |
|
2014 |
38 |
S1 |
p. S11- 1 p. |
artikel |
157 |
SP-015 NEW TARGETS IN ALL
|
Chiaretti, Sabina |
|
2014 |
38 |
S1 |
p. S7- 1 p. |
artikel |
158 |
SP-016 NEW TARGETS IN AML
|
Yilmaz, Mehmet |
|
2014 |
38 |
S1 |
p. S7-S9 3 p. |
artikel |
159 |
SP-005 NEXT GENERATION MICRO-ANALYSIS AND DIAGNOSIS USING COMPUTATIONAL IMAGING, CROWD-SOURCING AND GAMING
|
Ozcan, Aydogan |
|
2014 |
38 |
S1 |
p. S3- 1 p. |
artikel |
160 |
SP-034 NON-TRANSPLANT TREATMENT OF ACQUIRED APLASTIC ANEMIA
|
Ünal, Ali |
|
2014 |
38 |
S1 |
p. S17-S18 2 p. |
artikel |
161 |
SP-030 OPTIMIZING TREATMENT OF MULTIPLE MYELOMA COMPLICATIONS
|
Terpos, Evangelos |
|
2014 |
38 |
S1 |
p. S15- 1 p. |
artikel |
162 |
SP-019 PATHOGENETIC TREATMENT OF PNH AND AHUS: RUSSIAN EXPERIENCE
|
Lisukov, Igor |
|
2014 |
38 |
S1 |
p. S10- 1 p. |
artikel |
163 |
SP-055 PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
|
Anak, S. Sema |
|
2014 |
38 |
S1 |
p. S22-S23 2 p. |
artikel |
164 |
SP-060 PNH: A MULTISYSTEMIC AND MULTIDISCIPLINARY DISEASE
|
Sahin, Fahri |
|
2014 |
38 |
S1 |
p. S24-S25 2 p. |
artikel |
165 |
SP-017 PRODUCTS SITUATION OF THE BIOSIMILARS IN TURKEY AND IN THE WORLD
|
Iskit, Alper B. |
|
2014 |
38 |
S1 |
p. S10- 1 p. |
artikel |
166 |
SP-022 PROPHYLACTIC ANTIFUNGAL TREATMENT IN HEMATOLOGIC MALIGNANCIES
|
Senol, Esin |
|
2014 |
38 |
S1 |
p. S11- 1 p. |
artikel |
167 |
SP-057 RARE BLEEDING DISORDERS: UPDATE ON DIAGNOSIS AND MANAGEMENT, ROLE OF PRENATAL DIAGNOSIS AND PROPHYLAXIS
|
Farah, Roula |
|
2014 |
38 |
S1 |
p. S23-S24 2 p. |
artikel |
168 |
SP-035 RATIONAL DRUG USE AND PHARMACEUTICAL INDUSTRY
|
Koc, S. Tugba |
|
2014 |
38 |
S1 |
p. S18-S19 2 p. |
artikel |
169 |
SP-064 RESULTS OF AUTOLOGOUS PERIPHERAL HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR PATIENTS WITH MULTIPLE MYELOMA WITHOUT MAINTENANCE THERAPY
|
Jusupova, K. |
|
2014 |
38 |
S1 |
p. S26- 1 p. |
artikel |
170 |
SP-063 THE BORTEZOMIB + CHOP SCHEME IN PATIENTS WITH REFRACTORY FORM OF NON-HODGKIN'S LYMPHOMA
|
Karakulov, R.K. |
|
2014 |
38 |
S1 |
p. S26- 1 p. |
artikel |
171 |
SP-004 THE ESSENTIAL MANAGEMENT OF ADULT ALL
|
Hoelzer, Dieter |
|
2014 |
38 |
S1 |
p. S3- 1 p. |
artikel |
172 |
SP-002 THE ESSENTIAL MANAGEMENT OF AML
|
Burnett, Alan K. |
|
2014 |
38 |
S1 |
p. S2- 1 p. |
artikel |
173 |
SP-058 THE FUTURE TREATMENT LANDSCAPE FOR HEMOPHILIA
|
Mathew, Prasad |
|
2014 |
38 |
S1 |
p. S24- 1 p. |
artikel |
174 |
SP-037 TRANSPLANT IN THALASSEMIA: AN UPDATE
|
Pilo, Federica |
|
2014 |
38 |
S1 |
p. S19- 1 p. |
artikel |
175 |
SP-029 WHAT ARE THE NEW AGENTS IN THE MANAGEMENT OF PATIENTS WITH MULTIPLE MYELOMA?
|
Abonour, Rafat |
|
2014 |
38 |
S1 |
p. S14-S15 2 p. |
artikel |
176 |
SP-052 WHEN TO CONSIDER BONE MARROW TRANSPLANT IN SCD?
|
Alkindi, Salam |
|
2014 |
38 |
S1 |
p. S21-S22 2 p. |
artikel |
177 |
Welcome Address
|
|
|
2014 |
38 |
S1 |
p. v- 1 p. |
artikel |